Diagnostics Screening and monitoring, Clinical care

Five Reasons to implement LC-MS platforms for your laboratory developed tests

Implementing LC-MS requires sufficient justification and commitment of resources but can have a very positive impact on clinical and business goals.

contributed by Thermo Fisher Scientific | 06/16/2020

Technological advancements in Liquid Chromatography (LC) coupled to Mass Spectrometry (MS) technology, especially in the last decade, have opened several options to leverage this technology in the clinical diagnostic laboratory arena. Hence, from the analysis of acylcarnitines and amino acids in neonatal blood spots during the early 90s, LC-MS technology is now being used for other applications, such as endocrinology, toxicology, pharmacology, and therapeutic drug monitoring. However, it is still far from being considered as the “first choice” when it comes to deciding the technology for laboratory developed tests (LDTs).

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.